Kidney Carcinoma — Trials

Kidney Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,681 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 398
Recruiting: 202
Ph III recruiting: 17
Growth YoY: +1.2%
Industry share: 32%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 39.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (283)

clinicaltrialsPublishedShowing 151–156 of 156 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01041482	A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma(AGuo)	unknown	Phase 2	140	Chinese Academy of Medical SciencesOTHER	1	Jan 6, 2010	clinicaltrials
NCT00869011	Exercise for Patients With Renal Cell Cancer Receiving Sunitinib	unknown	Phase 3	70	Charite University, Berlin, GermanyOTHER	1	Dec 23, 2009